Literature DB >> 22362306

Tumour immunology: A close-range dual hit for tumour immunity.

Olive Leavy.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22362306     DOI： 10.1038/nri3189

Source DB:  PubMed          Journal:  Nat Rev Immunol        ISSN： 1474-1733            Impact factor:   53.106


× No keyword cloud information.
  2 in total

1.  Beyond pattern recognition: five immune checkpoints for scaling the microbial threat.

Authors:  J Magarian Blander; Leif E Sander
Journal:  Nat Rev Immunol       Date:  2012-02-24       Impact factor: 53.106

2.  Simultaneous targeting of toll- and nod-like receptors induces effective tumor-specific immune responses.

Authors:  Johan Garaude; Andrew Kent; Nico van Rooijen; J Magarian Blander
Journal:  Sci Transl Med       Date:  2012-02-08       Impact factor: 17.956
  2 in total
  3 in total

1.  Tailoring CD19xCD3-DART exposure enhances T-cells to eradication of B-cell neoplasms.

Authors:  Paola Circosta; Angela Rita Elia; Indira Landra; Rodolfo Machiorlatti; Maria Todaro; Sabrina Aliberti; Davide Brusa; Silvia Deaglio; Sabina Chiaretti; Riccardo Bruna; Daniela Gottardi; Massimo Massaia; Filomena Di Giacomo; Anna Rita Guarini; Robin Foà; Peter W Kyriakides; Rohan Bareja; Olivier Elemento; Gurunadh R Chichili; Emanuele Monteleone; Paul A Moore; Syd Johnson; Ezio Bonvini; Alessandro Cignetti; Giorgio Inghirami
Journal:  Oncoimmunology       Date:  2018-02-08       Impact factor: 8.110

2.  Thermal treatment of luteolin-7-O-β-glucoside improves its immunomodulatory and antioxidant potencies.

Authors:  Mouna Maatouk; Nadia Mustapha; Imen Mokdad-Bzeouich; Hind Chaaban; Besma Abed; Irina Iaonnou; Kamel Ghedira; Mohamed Ghoul; Leila Chekir Ghedira
Journal:  Cell Stress Chaperones       Date:  2017-06-04       Impact factor: 3.827

Review 3.  Monocyte/macrophage inflammatory response pathways to combat Francisella infection: possible therapeutic targets?

Authors:  Devyn D Gillette; Susheela Tridandapani; Jonathan P Butchar
Journal:  Front Cell Infect Microbiol       Date:  2014-02-21       Impact factor: 5.293
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.